Last reviewed · How we verify

Ultracet Tablets

Pfizer · FDA-approved active Small molecule

Ultracet combines tramadol (an opioid agonist and monoamine reuptake inhibitor) with acetaminophen to provide analgesia through dual pathways of pain relief.

Ultracet combines tramadol (an opioid agonist and monoamine reuptake inhibitor) with acetaminophen to provide analgesia through dual pathways of pain relief. Used for Moderate acute pain in adults.

At a glance

Generic nameUltracet Tablets
Also known asReference drug
SponsorPfizer
Drug classOpioid analgesic combination
TargetMu-opioid receptor; norepinephrine and serotonin transporters; COX enzymes
ModalitySmall molecule
Therapeutic areaPain Management
PhaseFDA-approved

Mechanism of action

Tramadol acts as a weak mu-opioid receptor agonist and inhibits the reuptake of norepinephrine and serotonin, enhancing descending pain inhibitory pathways. Acetaminophen works through poorly understood mechanisms involving central COX inhibition and endocannabinoid system modulation. Together, these agents provide synergistic pain relief for moderate acute pain.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results